Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 11Unknown 3Terminated 3Recruiting 2Suspended 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 14Thoracic 13Breast 11Other hematologic neoplasm 7Genitourinary 5Sarcoma 4Lymphoid 4Head & Neck 3Dermatologic 3CNS 3Tumor-Agnostic 2Other solid neoplasm 1Myeloid 1Gynecologic 1Classical hematology 1

Conditions

Melanoma 3Neoplasms 1

Interventions

pembrolizumab 58Ipilimumab 53Cyclophosphamide 53Nivolumab 45aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 19dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11spartalizumab 10Filgrastim 10Dacarbazine 10cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Drug Therapy × Dermatologic × Clear all
NCT00707161 2017-03-31

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

University of Utah

Phase 2 Terminated
6 enrolled 4 charts
Dermatologic

Melanoma, Neoplasms

NCT00003715 2015-12-03

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

AVAX Technologies

Phase 2 Terminated
425 enrolled
Dermatologic

Melanoma

NCT01709162 2015-11-30

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

Bristol-Myers Squibb

Phase 2 Terminated
31 enrolled 11 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡